Wednesday, December 15, 2021

Three...

Kam ended up having only a couple minor blisters on his feet with his last round of (Methotrexate) chemotherapy. He returned to the cancer clinic on Thursday, and while he was close, he didn't quite make counts to proceed with his in-clinic Doxorubicin. They told him to enjoy his weekend and come back on Tuesday. Kam was thrilled because that meant he would get the week of his upcoming 20th birthday and Christmas off for a break, instead of being hospitalized on Christmas for more chemo! Silver linings. 

Yesterday, in clinic, Kam made counts and got his first of two infusions of his very last round of the Doxorubicin. He is currently receiving his second (last) infusion today. Kam has gotten through all of these rounds without any evidence of cardiac toxicity, which is huge! Cardiac side effects are common with this type of chemotherapy, and so far Kameron's EKG's and echocardiograms look identical to his pre-treatment studies. 

We are amazed at all Kameron has been through. He has largely maintained a strong "let's do this" demeanor throughout these past 9 months of treatment. His body has been through so much. But physically, aside from some minor high frequency hearing loss and temporary blisters-- you'd never even know it. 

After today, Kam has just 2 chemotherapy treatments left. These will be hospital stays which, he doesn't enjoy. We are hopeful that these will feel easier for us, as these are the last two chemotherapy regimens of his planned MAP treatment.

We plan to thoroughly enjoy Kameron's 20th birthday and Christmas with the family next week. We were surprised with a sweet and generous secret Santa gift this past weekend that warmed every single one of our hearts. Thank you, whoever you are. It meant a lot. ❤

Thank you to each one of you who has reached out to us, checked in on as, and genuinely asked how we are. It's kept our spirits up and the demeanor to keep on going. Merry Christmas to you and yours, friends. 

❤Love, The Maddux Family

No comments:

Post a Comment